nimodipine has been researched along with Hyperglycemia in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Preischemic hyperglycemia is recognized to increase ischemic tissue acidosis and the present studies were undertaken to correlate depolarization and tissue acidosis during acute focal cerebral ischemia and hyperglycemia." | 5.30 | In vivo uptake of [3H]nimodipine in focal cerebral ischemia: modulation by hyperglycemia. ( Hogan, MJ; Osuga, S, 1997) |
| "Nimodipine-treated rats received the drug as an intravenous infusion of 0." | 5.28 | Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats. ( Berger, L; Hakim, AM, 1989) |
| "Preischemic hyperglycemia is recognized to increase ischemic tissue acidosis and the present studies were undertaken to correlate depolarization and tissue acidosis during acute focal cerebral ischemia and hyperglycemia." | 1.30 | In vivo uptake of [3H]nimodipine in focal cerebral ischemia: modulation by hyperglycemia. ( Hogan, MJ; Osuga, S, 1997) |
| "Nimodipine-treated rats received the drug as an intravenous infusion of 0." | 1.28 | Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats. ( Berger, L; Hakim, AM, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, H | 1 |
| James, ML | 1 |
| Venkatraman, TN | 1 |
| Wilson, LJ | 1 |
| Lyuboslavsky, P | 1 |
| Myers, SJ | 1 |
| Lascola, CD | 1 |
| Laskowitz, DT | 1 |
| Osuga, S | 1 |
| Hogan, MJ | 1 |
| Berger, L | 1 |
| Hakim, AM | 1 |
3 other studies available for nimodipine and Hyperglycemia
| Article | Year |
|---|---|
pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH.
Topics: Animals; Behavior, Animal; Calcium Channel Blockers; Disease Models, Animal; Hydrogen-Ion Concentrat | 2014 |
In vivo uptake of [3H]nimodipine in focal cerebral ischemia: modulation by hyperglycemia.
Topics: Animals; Autoradiography; Blood Flow Velocity; Calcium Channel Blockers; Cerebral Cortex; Corpus Str | 1997 |
Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats.
Topics: Acidosis; Animals; Brain Diseases; Brain Ischemia; Cerebrovascular Circulation; Hydrogen-Ion Concent | 1989 |